澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Opthea Ltd

0.400

0.000

成交量：- -

成交額：- -

市值：5.47億

市盈率：- -

高：0.400

開：0.400

低：0.400

收：0.400

52周最高：0.620

52周最低：0.300

股本：13.68億

流通股本：7.96億

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Opthea Ltd

交易所：

ASX

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.opthea.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Opthea Limited於1984年根據澳大利亞法律註冊成立，名稱為Circadian Technologies Limited。該公司是一家臨床階段生物製藥公司，致力於開發一種新型療法，用於治療高度流行和進行性視網膜疾病。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/OPTOB.AU/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OPTOB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OPTOB.AU\",,,,,undefined,":{"symbol":"OPTOB.AU","market":"AU","secType":"STK","nameCN":"Opthea Ltd","latestPrice":0.4,"timestamp":1766466720000,"preClose":0.4,"halted":0,"volume":0,"delay":0,"nameEN":"Opthea Ltd","floatShares":796000000,"shares":1368000000,"eps":0,"marketStatus":"未開盤","change":0,"latestTime":"12-23 16:12:00 AEDT","open":0.4,"high":0.4,"low":0.4,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1766530800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.4,"openAndCloseTimeList":[[1766444400000,1766466000000]],"volumeRatio":0,"lotSize":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OPTOB.AU\",,,,,undefined,":{"symbol":"OPTOB.AU","floatShares":796000000,"roa":"--","roe":"--","lyrEps":0,"shares":1368000000,"dividePrice":0,"high":0.4,"amplitude":0,"preClose":0.4,"low":0.4,"week52Low":0.3,"pbRate":"--","week52High":0.62,"institutionHeld":0,"latestPrice":0.4,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.4,"prevYearClose":0.36,"prevWeekClose":0.4,"prevMonthClose":0.4,"prevQuarterClose":0.4,"fiveDayClose":0.4,"twentyDayClose":0.4,"sixtyDayClose":0.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OPTOB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OPTOB.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.opthea.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0.4286},{"period":"ytd","weight":0.1111}],"compareEarnings":[{"period":"1week","weight":0.0168},{"period":"1month","weight":0.0421},{"period":"3month","weight":0.0657},{"period":"6month","weight":0.1033},{"period":"1year","weight":0.2613},{"period":"ytd","weight":0.2552}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Opthea Limited於1984年根據澳大利亞法律註冊成立，名稱為Circadian Technologies Limited。該公司是一家臨床階段生物製藥公司，致力於開發一種新型療法，用於治療高度流行和進行性視網膜疾病。","exchange":"ASX","name":"Opthea Ltd","nameEN":"Opthea Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OPTOB.AU\",market:\"AU\",,,undefined,":null}}